BFLY is trading 4.9% up today at $9.32, extending its recent rally. - The stock continues to see strong investor interest following its co-development and licensing deal with Midjourney Medical, which could be worth up to $74M over five years. - Additionally, Butterfly Network announced a board change, putting Caroll H. Neubauer's medtech experience in focus on June 29, 2026. - The company's ultrasound-on-chip technology and profile as a fast-growing firm are contributing to positive sentiment.